Pro Share Advisors LLC Allakos Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$1.02 - $3.23 $1,089 - $3,449	1,068 Added 9.71%	12,070 $15,000
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $5,703 - $10,544	-3,316 Reduced 23.16%	11,002 $30,000
Q3 2023 Nov 13, 2023	BUY	$2.13 - $5.55 $153 - $399	72 Added 0.51%	14,318 $32,000
Q2 2023 Aug 10, 2023	BUY	$3.6 - $5.25 $51,285 - $74,791	14,246 New	14,246 $62,000
Q2 2022 Aug 01, 2022	SELL	$2.6 - $6.14 $31,909 - $75,356	-12,273 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$5.08 - $9.81 $15,869 - $30,646	-3,124 Reduced 20.29%	12,273 $70,000
Q4 2021 Feb 08, 2022	SELL	$8.55 - $111.89 $5,266 - $68,924	-616 Reduced 3.85%	15,397 $150,000
Q3 2021 Nov 12, 2021	SELL	$76.53 - $110.43 $205,023 - $295,841	-2,679 Reduced 14.33%	16,013 $1.7 Million
Q2 2021 Aug 13, 2021	BUY	$85.37 - $114.1 $377,250 - $504,207	4,419 Added 30.96%	18,692 $1.6 Million
Q1 2021 May 14, 2021	BUY	$109.73 - $153.66 $39,173 - $54,856	357 Added 2.57%	14,273 $1.64 Million
Q4 2020 Feb 09, 2021	BUY	$79.58 - $152.45 $242,480 - $464,515	3,047 Added 28.03%	13,916 $1.95 Million
Q3 2020 Nov 13, 2020	SELL	$66.43 - $90.99 $15,544 - $21,291	-234 Reduced 2.11%	10,869 $885,000
Q2 2020 Aug 03, 2020	BUY	$44.04 - $80.69 $143,438 - $262,807	3,257 Added 41.51%	11,103 $798,000
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $236,597 - $496,648	-5,318 Reduced 40.4%	7,846 $349,000
Q4 2019 Feb 12, 2020	SELL	$66.49 - $137.73 $143,551 - $297,359	-2,159 Reduced 14.09%	13,164 $1.26 Million
Q3 2019 Nov 12, 2019	BUY	$31.0 - $89.73 $37,944 - $109,829	1,224 Added 8.68%	15,323 $1.21 Million
Q2 2019 Aug 13, 2019	SELL	$36.0 - $44.73 $63,036 - $78,322	-1,751 Reduced 11.05%	14,099 $611,000
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $23,348 - $35,925	691 Added 4.56%	15,850 $642,000
Q4 2018 Feb 14, 2019	BUY	$31.59 - $62.65 $478,872 - $949,711	15,159 New	15,159 $792,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$21 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$7.81 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$6.35 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$4.46 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.91 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $108M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account